captopril has been researched along with atenolol in 127 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (22.83) | 18.7374 |
| 1990's | 49 (38.58) | 18.2507 |
| 2000's | 30 (23.62) | 29.6817 |
| 2010's | 18 (14.17) | 24.3611 |
| 2020's | 1 (0.79) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Brunner, HR; Hayoz, D; Meister, JJ; Perret, F; Tardy, Y; Waeber, B | 1 |
| Andrews, CD; Bulpitt, CJ; Callaghan, TS; Fletcher, AE; Palmer, AJ; Rudge, PJ | 1 |
| Thurston, H | 1 |
| Dohmoto, H; Fujiyoshi, T; Hashiguchi, Y; Hayashi, Y; Hosono, M; Iida, H; Ikeda, K; Yoshimoto, R | 1 |
| Goldstein, RJ | 1 |
| Desche, P; Thurston, H | 1 |
| Koene, FM; Tan, ES; Van Baak, MA; Verstappen, FT | 1 |
| Capewell, S; Deary, IJ; Hajducka, C; Muir, AL | 1 |
| Lithell, HO | 1 |
| Cai, B | 1 |
| Coutard, M; Osborne-Pellegrin, M | 1 |
| Havinga, TK; May, JF; Schuurman, FH; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
| Kumar, K; Rajan, AG; Somani, PN; Sundar, S | 1 |
| Chittora, M; Lakhotia, M; Mehta, S; Parihar, M; Shah, PK; Vyas, R | 1 |
| Herlitz, H | 1 |
| Dzau, VJ; Stevenson, L; Tang, SS | 1 |
| Bulpitt, CJ; Fletcher, AE; Havinga, TK; Hawkins, CM; May, JF; Schuurman, FH; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
| Barlassina, C; Bianchi, G; Cesana, B; Colombo, R; Cusi, D; Niutta, E; Pellizzoni, M; Soldati, L | 1 |
| Friedhoff, AJ; Santo, JP; Steiner, SS; Wecker, JR; Wilson, BL | 1 |
| Curry, C; Gray, J; Hollifield, J; Kong, BW; Saunders, E; Schoenberger, J; Sowers, JR; Vertes, V; Weir, MR; Zemel, MB | 1 |
| Baume, RM; Croog, SH; Kong, BW; Levine, S; Saunders, E; Weir, MR | 1 |
| Friedler, A; Mor, F; Shapira, Y; Weinberger, A; Wysenbeek, AJ | 1 |
| Currie, D; Lewis, RV; McDevitt, DG; Nicholson, AN; Wright, NA | 1 |
| Currie, D; McDevitt, DG; Nicholson, AN; Wright, NA; Zetlein, MB | 2 |
| Desche, P; Zanchetti, A | 2 |
| Watari, H | 1 |
| de Nobel, E; Elving, LD; Thien, T; van Lier, HJ | 1 |
| Fukuyama, M; Okabayashi, H; Takahashi, H; Yoneda, S; Yoshimura, M | 1 |
| Majewski, H; Rump, LC | 1 |
| Breckenridge, AM; Grimmer, SF; Orme, ML; Roberts, DH; Tsao, Y; Winstanley, PA | 1 |
| Breckenridge, A; McLoughlin, GA; Roberts, DH; Tsao, Y | 1 |
| Sen, S; Young, DR | 1 |
| Sen, S | 1 |
| Chandra, M; Kumar, A; Misra, R; Pandeya, SN; Singh, SP | 1 |
| Leary, WP; Maharaj, B; van der Byl, KV | 1 |
| Alberghini, E; Barlassina, C; Bianchi, G; Cesana, B; Colombo, R; Cusi, D; Niutta, E; Pati, P; Pellizzoni, M; Tripodi, G | 1 |
| Kumagai, H; Saruta, T; Suzuki, H; Tominaga, T | 1 |
| Blake, S; Carey, M | 1 |
| Buchholz, RA; Hubbard, JW; Keeton, TK; Nathan, MA | 1 |
| Petrella, V | 1 |
| Lovell, HG; Petrie, JC; Robb, OJ; Webster, J; Witte, K | 1 |
| Beevers, DG; Potter, JF | 1 |
| Bianchi, G; Cusi, D; Dossi, F; Elli, A; Niutta, E; Pati, C; Tripodi, MG | 1 |
| Andrén, L; Hansson, L; Karlberg, BE; Nilsson, OR; Ohman, P; Svensson, A | 1 |
| Conway, J | 1 |
| Vidt, DG | 1 |
| Andrén, L; Hansson, L; Svensson, A | 1 |
| Freslon, JL; Giudicelli, JF; Richer, C | 1 |
| Andrén, L; Asplund, J; Hansson, L; Karlberg, B; Ohman, P; Svensson, A | 1 |
| Arzilli, F; Pedrinelli, R; Salvetti, A; Sassano, P; Turini, F | 1 |
| Freslon, JL; Giudicelli, JF; Glasson, S; Richer, C | 1 |
| Labeeuw, M; Trotta, P; Zech, PY | 1 |
| Gil-Extremera, B; González-Gómez, L; Luna del Castillo, JD; Maldonado-Martín, A; Rubio-Luengo, MA | 1 |
| Bamrah, VS; Forbes, M; Kochar, MS; Kotecki, G; Trottier, D | 1 |
| Hardy, KJ | 1 |
| Berden, JH; de Nobel, E; Elving, LD; van Lier, HJ; Wetzels, JF | 1 |
| Cushman, WC; Freis, ED; Fye, C; Gottdiener, J; Hamburger, RJ; Kochar, MS; Lakshman, R; Massie, BM; Materson, BJ; Reda, DJ | 1 |
| Bevan, EG; Carmichael, HA; Findlay, JG; Herrick, AL; Lorimer, AR; Murray, GD; Pringle, SD; Reid, JL; Waller, PC; Weir, RJ | 1 |
| Maritz, FJ; Schoeman, HS; Weich, HF | 1 |
| Jonkmann, JH; Schmidtke-Schrezenmeier, G; Tam, YK; van Brummelen, P; Weber, C | 1 |
| Anson, O; Neumann, L; Paran, E | 1 |
| Arsenescu, I; Provendier, O; Witchitz, S | 1 |
| Anderson, RJ; Gottdiener, JS; Massie, BM; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Elijovich, F; Laffer, CL; Schiffrin, EL | 1 |
| Gaur, A; Kaushik, S; Kher, V; Tripathi, M | 1 |
| Miser, WF | 1 |
| Berglund, E; Dahlöf, C; Engqvist, L; Lagerstedt, C; Lehtonen, A; Nilsson-Ehle, P; Thulin, T | 1 |
| Aakhus, S; Dahl, K; Skjaerpe, T; Soma, J; Widerøe, TE | 1 |
| Cushman, WC; Freis, ED; Lakshman, MR; Materson, BJ; Reda, DJ | 1 |
| Foss, OP; Graff-Iversen, S; Graving, B; Istad, H; Søyland, E; Tjeldflaat, L | 1 |
| Martin, ME | 1 |
| Bakir, S; Oparil, S | 1 |
| Bagirova, GG; Batalina, MV | 1 |
| Castillo-Soria, FJ; de La Rosa, JA; Florenciano-Sánchez, R; Galcerá-Tomás, J; Iñigo-García, L; Jara-Pérez, P; López-Martínez, I; Martínez-Caballero, A; Párraga-Ramírez, M; Picó-Aracil, F; Sánchez-Villanueva, JG; Valentí-Aldeguer, JA; Villegas-García, MM | 1 |
| Levinson, PD | 1 |
| Mazur, NA; Vikent'ev, VV | 1 |
| Ball, KJ; Stumpe, KO; Williams, PA | 1 |
| Adler, A; Clarke, P; Cull, C; Gray, A; Holman, R; Neil, A; Raikou, M; Stevens, R; Stratton, I | 1 |
| Cushman, WC; Materson, BJ; Reda, DJ; Williams, DW | 1 |
| Caro, JJ; Lee, K | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Gao, L; Kern, TS; Widness, M; Xi, X; Zhang, JZ | 1 |
| Chichorro, JG; Lorenzetti, BB; Zampronio, AR | 1 |
| Aldington, SJ; Holman, RR; Kohner, EM; Matthews, DR; Stratton, IM | 1 |
| Bertoluci, MC; Oliveira, FR; Schmid, H; Schmidt, A; Thomazelli, FC; Uebel, D | 1 |
| Shen, FM; Su, DF; Wang, J; Wang, MW; Zhang, XF | 1 |
| Feely, J; Mahmud, A | 1 |
| Boccioletti, V; Cominacini, L; Fabrizzi, P; Garbin, U; Lo Cascio, V; Luchetta, ML; Nava, MC; Pasini, AF; Pellegrini, M; Stranieri, C | 1 |
| Nilsson, P | 1 |
| Bai, Y; Chen, J; Fan, X; Fu, C; Han, Y; Hui, R; Li, W; Shi, Y; Song, X; Sun, K; Wang, H; Wang, Y; Wu, H; Xin, Y; Yang, T; Zhou, X | 1 |
| Brody, R; Grossman, E; Peleg, E; Sharabi, Y | 1 |
| Cameron, A; Ewen, M; Laing, RO; van Mourik, MS | 1 |
| Hosseini, F; Mahmoudian, M; Nemati, F; Rahbar-Roshandel, N; Shafiei, M | 1 |
| Huang, Y; Shan, Z; Wang, C; Wang, Q; Yan, K; Yan, W; Zhang, Y | 1 |
| Jan, MY; Wang, SH; Wang, WK; Wang, YY | 1 |
| Anhê, GF; Antunes, E; Calmasini, F; Faria, Jde A; Mónica, FZ; Moscoso, JA; Ramos-Filho, AC | 1 |
| Hasanzadeh, M; Niaei, N; Shadjou, N | 1 |
| de Moura Leão, MF; de Oliveira, LFS; Duarte, JA; Machado, MM; Piccoli, JDCE; Sauzen, PD | 1 |
| Athanasiou, A; Iliopoulos, DC; Paschou, SA; Patelis, N; Siasos, G; Spartalis, E; Spartalis, M; Tzatzaki, E; Voudris, V | 1 |
8 review(s) available for captopril and atenolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
ACE-inhibitors and quality of life.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Enalapril; Health Status; Humans; Hypertension; Methyldopa; Middle Aged; Oxprenolol; Quality of Life | 1990 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
Beta-blockers, diabetes, and hypoglycemia: risky business?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Randomized Controlled Trials as Topic; Risk Factors; Time Factors | 2001 |
Combination therapy as first-line treatment of arterial hypertension.
Topics: Antihypertensive Agents; Atenolol; Captopril; Diltiazem; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Prazosin; Treatment Outcome | 2002 |
69 trial(s) available for captopril and atenolol
| Article | Year |
|---|---|
Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Atenolol; Blood Pressure; Captopril; Compliance; Dipeptides; Double-Blind Method; Humans; Hydralazine; Hypertension; Lisinopril; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ultrasonography | 1992 |
Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trial.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Quality of Life | 1992 |
Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1992 |
The treatment of moderate to severe hypertension with ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isoquinolines; Multicenter Studies as Topic; Quinapril; Tetrahydroisoquinolines | 1990 |
Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Topics: Amiloride; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Perindopril | 1991 |
Exercise performance during captopril and atenolol treatment in hypertensive patients.
Topics: Atenolol; Captopril; Double-Blind Method; Exercise; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Oxygen Consumption; Pulmonary Gas Exchange | 1991 |
The effects of captopril vs atenolol on memory, information processing and mood: a double-blind crossover study.
Topics: Adult; Affect; Aged; Atenolol; Blood Pressure; Captopril; Cognition; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Memory | 1991 |
Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Double-Blind Method; Glucose; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Meta-Analysis as Topic; Metoprolol; Pindolol; Propranolol; Prospective Studies | 1991 |
Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
Topics: Adult; Atenolol; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors | 1991 |
The effects of antihypertensive agents on the quality of life in Indian hypertensives.
Topics: 1-Propanol; Adult; Aged; Atenolol; Captopril; Data Collection; Humans; Hypertension; India; Male; Middle Aged; Nifedipine; Quality of Life | 1991 |
Cardiovascular response to dynamic treadmill exercise in patients with essential hypertension before and after therapy with atenolol or captopril.
Topics: Adult; Atenolol; Blood Pressure; Body Weight; Captopril; Exercise Test; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Reference Values | 1990 |
Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol.
Topics: Affect; Atenolol; Captopril; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic | 1990 |
Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
Topics: Adolescent; Adult; Atenolol; Blood Pressure; Canrenoic Acid; Captopril; Erythrocyte Membrane; Female; Humans; Hypertension; Male; Middle Aged; Potassium; Renin; Sodium; Sodium Channels | 1990 |
Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
Topics: Adult; Aged; Analysis of Variance; Atenolol; Captopril; Cognition; Double-Blind Method; Enalapril; Humans; Hypertension; Male; Middle Aged; Propranolol; Psychometrics; Quality of Life; Randomized Controlled Trials as Topic; Sexual Behavior; Sleep; Surveys and Questionnaires | 1990 |
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.
Topics: Adult; Aged; Atenolol; Black People; Captopril; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Renin; Supination; Verapamil | 1990 |
Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group.
Topics: Age Factors; Antihypertensive Agents; Atenolol; Black or African American; Black People; Captopril; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Quality of Life; Randomized Controlled Trials as Topic; Sex Factors; Verapamil | 1990 |
Central effects of the angiotensin-converting enzyme inhibitor, captopril. I. Performance and subjective assessments of mood.
Topics: Adult; Affect; Atenolol; Blood Pressure; Captopril; Heart Rate; Humans; Hypertension; Male; Oxazepam; Psychomotor Performance | 1990 |
Central effects of the angiotensin-converting enzyme inhibitor, captopril. II. Electroencephalogram and body sway.
Topics: Atenolol; Captopril; Electroencephalography; Humans; Male; Oxazepam; Postural Balance | 1990 |
[Perindopril: first-line treatment of arterial hypertension].
Topics: Adolescent; Adult; Aged; Amiloride; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials as Topic; Diuretics; Drug Evaluation; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Male; Middle Aged; Multicenter Studies as Topic; Perindopril; Random Allocation | 1989 |
A comparison of the hypotensive effects of captopril and atenolol in the treatment of hypertension in diabetic patients.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Captopril; Clinical Trials as Topic; Diabetes Complications; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Random Allocation; Renin | 1989 |
Comparison of nisoldipine and atenolol in the treatment of essential hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Calcium Channel Blockers; Captopril; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nisoldipine; Random Allocation; Renin; Stress, Physiological | 1989 |
Perindopril: first-line treatment for hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Diuretics; Double-Blind Method; Humans; Hypertension; Indoles; Middle Aged; Multicenter Studies as Topic; Perindopril | 1989 |
Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Topics: Adrenergic beta-Antagonists; Atenolol; Blood Pressure; Captopril; Female; Forearm; Heart; Heart Rate; Hemodynamics; Humans; Hypertension; Labetalol; Leg; Male; Middle Aged; Myocardial Contraction; Pindolol; Regional Blood Flow; Vascular Resistance | 1987 |
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Topics: Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Intermittent Claudication; Labetalol; Leg; Male; Middle Aged; Pindolol; Random Allocation | 1987 |
A comparison of captopril and atenolol in addition to hydrochlorothiazide for the treatment of hypertension.
Topics: Adult; Atenolol; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 1988 |
Antihypertensive effect of captopril, canrenoate potassium, and atenolol. Relations with red blood cell sodium transport and renin.
Topics: Adolescent; Adult; Atenolol; Biological Transport; Blood Pressure; Canrenoic Acid; Captopril; Erythrocyte Membrane; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pregnadienes; Renin; Sodium | 1988 |
Effects of first-line antihypertensive agents on sexual function and sex hormones.
Topics: Adult; Antihypertensive Agents; Atenolol; Captopril; Estradiol; Follicle Stimulating Hormone; Humans; Hypertension; Luteinizing Hormone; Male; Middle Aged; Nifedipine; Sexual Dysfunction, Physiological; Testosterone; Trichlormethiazide | 1988 |
Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
Topics: Adult; Atenolol; Bendroflumethiazide; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Random Allocation | 1986 |
Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide.
Topics: Aged; Aldosterone; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Propranolol; Random Allocation; Renin | 1987 |
Atenolol improves blood pressure control in patients taking captopril and frusemide.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Random Allocation | 1987 |
Effects of captopril and of other antihypertensive drugs on cell membrane ion transport--a preliminary report.
Topics: Adolescent; Adult; Atenolol; Biological Transport; Blood Pressure; Canrenoic Acid; Captopril; Cations; Humans; Middle Aged; Sodium | 1986 |
Long-term effects of captopril and atenolol in essential hypertension.
Topics: Adult; Aged; Atenolol; Captopril; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Time Factors | 1985 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
Captopril or atenolol in essential hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Random Allocation | 1983 |
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.
Topics: Adult; Aged; Atenolol; Blood Pressure; Captopril; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Proline; Propanolamines; Renin-Angiotensin System | 1982 |
Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs.
Topics: Adult; Atenolol; Bumetanide; Captopril; Cold Temperature; Diuretics; Enzyme Precursors; Female; Glycolates; Humans; Hypertension; Hypertension, Renovascular; Indomethacin; Male; Middle Aged; Placebos; Proline; Propanolamines; Prostaglandins; Renin; Ticrynafen | 1982 |
Variations in magnesium and zinc in hypertensive patients receiving different treatments.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cholesterol, HDL; Erythrocytes; Female; Humans; Hypertension; Magnesium; Male; Middle Aged; Time Factors; Verapamil; Zinc | 1995 |
Sequential monotherapy of hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cross-Over Studies; Drug Administration Schedule; Female; Humans; Hypertension; Indapamide; Male; Middle Aged | 1994 |
Hypertension in Diabetes Study. III. Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade.
Topics: Adult; Aged; Atenolol; Blood Glucose; Blood Pressure; Body Weight; Captopril; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Triglycerides; United Kingdom | 1994 |
Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Topics: Adult; Albuminuria; Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Prospective Studies; Proteinuria; Treatment Outcome | 1994 |
Central effects of repeated administration of atenolol and captopril in healthy volunteers.
Topics: Adult; Atenolol; Attention; Blood Pressure; Captopril; Central Nervous System; Electroencephalography; Flicker Fusion; Heart Rate; Humans; Male; Memory, Short-Term; Mental Recall; Methyldopa; Oxazepam; Psychomotor Performance; Reaction Time | 1994 |
Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Age Factors; Aged; Antihypertensive Agents; Atenolol; Black People; Blood Pressure; Captopril; Clonidine; Delayed-Action Preparations; Diltiazem; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin | 1993 |
Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Renin; Treatment Outcome | 1993 |
A comparison of the metabolic effects of captopril and atenolol on glucose, insulin and lipoproteins in patients with mild-to-moderate essential hypertension.
Topics: Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Double-Blind Method; Humans; Hypertension; Insulin; Lipoproteins; Middle Aged | 1995 |
Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Chromatography, High Pressure Liquid; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Enzyme Inhibitors; Female; Furosemide; Humans; Hypertension; Lactones; Male; Nifedipine; Orlistat | 1996 |
Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cohort Studies; Diabetes Mellitus, Type 2; Electrolytes; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Prospective Studies; Time Factors | 1996 |
The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Propranolol; Quality of Life; Sodium Chloride Symporter Inhibitors; Surveys and Questionnaires | 1996 |
[Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial].
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Captopril; Double-Blind Method; Female; Humans; Hypercholesterolemia; Hypertension; Lipid Metabolism; Male; Middle Aged; Pravastatin; Time Factors | 1996 |
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Captopril; Clonidine; Cohort Studies; Diltiazem; Diuretics; Double-Blind Method; Echocardiography; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Organ Size; Prazosin; Prevalence; Risk Factors; Sodium Chloride Symporter Inhibitors; Treatment Outcome; United States; United States Department of Veterans Affairs | 1997 |
The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
Topics: Antihypertensive Agents; Atenolol; Atrial Natriuretic Factor; Blood Pressure; Captopril; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Hypertension | 1997 |
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Proteinuria; Visual Acuity; Weight Gain | 1998 |
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Hypoglycemia; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Peripheral Vascular Diseases; Prospective Studies; Treatment Outcome; Visual Acuity; Weight Gain | 1998 |
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Cost of Illness; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Health Services; Hospitalization; Humans; Hypertension; Life Expectancy; Male; Middle Aged; Prospective Studies; Quality-Adjusted Life Years; Sensitivity and Specificity; Time Factors; Treatment Outcome; United Kingdom | 1998 |
Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Diltiazem; Humans; Hypertension; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Quality of Life; Single-Blind Method; Time Factors; Uric Acid | 1999 |
Total arterial compliance in ambulatory hypertension during selective beta1-adrenergic receptor blockade and angiotensin-converting enzyme inhibition.
Topics: Adrenergic Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aorta; Atenolol; Blood Pressure; Captopril; Cross-Over Studies; Echocardiography, Doppler; Electrocardiography; Female; Humans; Hypertension; Male; Middle Aged; Ventricular Function | 1999 |
Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Blood Glucose; Captopril; Clonidine; Diltiazem; Diuretics; Double-Blind Method; Hospitals, Veterans; Humans; Hydrochlorothiazide; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Potassium; Prazosin; Time Factors; Treatment Outcome; United States | 1999 |
Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Atenolol; Captopril; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Life Style; Male; Middle Aged; Norway; Pravastatin; Statistics, Nonparametric | 1999 |
[Treatment of chronic heart failure in patients with mitral and aortic valve defects of rheumatic origin].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aortic Valve Insufficiency; Atenolol; Captopril; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis; Rheumatic Heart Disease | 2000 |
Effects of early use of atenolol or captopril on infarct size and ventricular volume: A double-blind comparison in patients with anterior acute myocardial infarction.
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Captopril; Coronary Angiography; Double-Blind Method; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Prospective Studies; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Function | 2001 |
[Postinfarction remodeling of the left atrium and left ventricle: effects of long-term treatment with beta adrenergic blockers and angiotensin converting enzyme inhibitors].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Atrial Function, Left; Captopril; Data Interpretation, Statistical; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Time Factors; Ventricular Remodeling | 2001 |
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54).
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Captopril; Confidence Intervals; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Family Practice; Follow-Up Studies; Glycated Hemoglobin; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Time Factors; Treatment Outcome; United Kingdom | 2001 |
Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Clonidine; Diastole; Diltiazem; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prazosin; Pressure; Pulse; Randomized Controlled Trials as Topic; Systole; Time Factors; Treatment Outcome | 2001 |
Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cataract Extraction; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypertension, Renal; Laser Coagulation; Male; Middle Aged; Prospective Studies; Risk Factors; Vision Disorders; Vitreous Hemorrhage | 2004 |
Urinary TGF-beta1 reduction related to a decrease of systolic blood pressure in patients with type 2 diabetes and clinical diabetic nephropathy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Potassium; Propranolol; Ramipril; Transforming Growth Factor beta1 | 2006 |
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Capsules; Captopril; Diuretics; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Glucose; Blood Pressure; Captopril; Cell Adhesion Molecules; Cholesterol, HDL; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Ramipril; Sulfhydryl Compounds; Triglycerides; Vasodilation | 2007 |
Antihypertensive efficacy of zofenopril compared with atenolol in patients with mild to moderate hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Time Factors; Treatment Outcome | 2007 |
Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Atenolol; Blood Pressure; Captopril; China; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nifedipine; Prospective Studies; Sex Factors | 2008 |
Tagging SNPs in REN, AGTR1 and AGTR2 genes and response of renin activity, angiotensin II and aldosterone concentrations to antihypertensive treatment in Kazakans.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; China; Double-Blind Method; Ethnicity; Female; Genetic Association Studies; Humans; Hypertension; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin | 2011 |
53 other study(ies) available for captopril and atenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in conscious spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Dihydropyridines; Heart Rate; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR | 1992 |
[The effect of lowered pressure on the diastolic ventricular function after antihypertensive treatment].
Topics: Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Cardiomegaly; Diastole; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Ultrasonography; Ventricular Function, Left | 1991 |
Rupture of the internal elastic lamina and vascular fragility in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Arteries; Atenolol; Blood Pressure; Capillary Fragility; Captopril; Cerebrovascular Disorders; Hydralazine; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Mutant Strains; Renal Artery; Rupture, Spontaneous; Vascular Diseases | 1991 |
Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Atenolol; Captopril; Cattle; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media; Endothelium, Vascular; Isoproterenol; Phenylephrine; Propanolamines; Radioimmunoassay; Receptors, Adrenergic, beta; Renin-Angiotensin System | 1990 |
Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
Topics: Adult; Atenolol; Body Weight; Captopril; Creatinine; Female; Furosemide; Humans; Hypertension; Lupus Nephritis; Nephrotic Syndrome; Proteinuria; Time Factors | 1990 |
[Significance of brain renin for pathogenesis of hypertension: effect of antihypertensive drugs on active and inactive renins in the brain of spontaneously hypertensive rat].
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Captopril; Enzyme Activation; Enzyme Precursors; Hypertension; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Trichlormethiazide | 1989 |
Beta adrenoceptor facilitation of norepinephrine release is not dependent on local angiotensin II formation in the rat isolated kidney.
Topics: Angiotensin II; Animals; Atenolol; Captopril; In Vitro Techniques; Isoproterenol; Kidney; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Saralasin | 1987 |
Role of sodium in modulation of myocardial hypertrophy in renal hypertensive rats.
Topics: Animals; Atenolol; Captopril; Cardiomegaly; Diet, Sodium-Restricted; Hypertension, Renovascular; Isoenzymes; Myocardium; Myosins; Rats | 1986 |
Factors regulating myocardial hypertrophy in hypertension.
Topics: Animals; Atenolol; Blood Pressure; Captopril; Cardiomegaly; Hypertension; Isoenzymes; Male; Myocardium; Myosins; Rats; Rats, Inbred Strains | 1987 |
Atenolol vs captopril as monotherapy in mild to moderate hypertension: alternative to empirical step care approach.
Topics: Adult; Atenolol; Blood Pressure; Captopril; Female; Humans; Hypertension; Male; Middle Aged | 1988 |
Parabrachial lesions increase plasma norepinephrine concentration, plasma renin activity and enhance baroreflex sensitivity in the conscious rat.
Topics: Animals; Atenolol; Blood Pressure; Captopril; Epinephrine; Heart Rate; Male; Norepinephrine; Pressoreceptors; Rats; Renin | 1987 |
[Thrombocytopenia caused by drugs: new molecules as the cause].
Topics: Aged; Aged, 80 and over; Atenolol; Captopril; Chlorthalidone; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; Thrombocytopenia | 1987 |
[Antihypertensives and the prevention of development of genetic hypertension in the hypertensive SHR rat].
Topics: Animals; Antihypertensive Agents; Atenolol; Captopril; Cardiomegaly; Dihydralazine; Dose-Response Relationship, Drug; Hydrochlorothiazide; Hypertension; Male; Nicardipine; Nifedipine; Prazosin; Rats; Rats, Inbred Strains; Time Factors; Vasodilator Agents | 1980 |
Captopril and hypertension development in the SHR.
Topics: Angiotensin II; Animals; Atenolol; Blood Pressure; Captopril; Dihydralazine; Hypertension; Male; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Vascular Resistance | 1980 |
[Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
Topics: Adult; Aged; Atenolol; Captopril; Diet, Sodium-Restricted; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Prazosin; Proline | 1981 |
Antihypertensives retarding progression of diabetic nephropathy.
Topics: Atenolol; Blood Pressure; Captopril; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans | 1995 |
Effect of antihypertensives on plasma potassium in end stage renal disease: a retrospective study.
Topics: Adolescent; Adult; Antihypertensive Agents; Atenolol; Captopril; Female; Humans; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Potassium; Retrospective Studies | 1997 |
Antihypertensive therapy in type 2 diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Humans; Hypertension; Middle Aged; Patient Selection; Research Design | 1998 |
Hypertension in the elderly.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials as Topic; Diabetes Complications; Humans; Hypertension; Risk Factors | 2000 |
Recent outcome trials of newer antihypertensives.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Captopril; Diabetic Angiopathies; Humans; Hypertension; Treatment Outcome | 1999 |
Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives.
Topics: Angiotensin II; Antihypertensive Agents; Atenolol; Captopril; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypertension; Imidazoles; Losartan; Multicenter Studies as Topic; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles | 2001 |
An economic evaluation of atenolol vs. captopril in patients with type 2 diabetes (UKPDS 24).
Topics: Antihypertensive Agents; Atenolol; Captopril; Diabetes Mellitus, Type 2; Evaluation Studies as Topic; Health Care Costs; Hospitalization; Humans; Randomized Controlled Trials as Topic; United Kingdom | 2002 |
Captopril inhibits glucose accumulation in retinal cells in diabetes.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Atenolol; Blood Glucose; Blotting, Western; Captopril; Cattle; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelium, Vascular; Glucose; Glucose Transporter Type 1; Lisinopril; Male; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels | 2003 |
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.
Topics: Animals; Arachidonic Acids; Atenolol; Behavior, Animal; Biogenic Amines; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Captopril; Celecoxib; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Facial Pain; Formaldehyde; Guanethidine; Hindlimb; Indomethacin; Injections, Subcutaneous; Interleukin-6; Interleukin-8; Lip; Male; Meloxicam; Nociceptors; Prostaglandins; Pyrazoles; Rats; Rats, Wistar; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Sulfonamides; Thiazines; Thiazoles; Tumor Necrosis Factor-alpha; Tyramine | 2004 |
Functional arterial baroreflex attenuates the effects of antihypertensive drugs in conscious rats.
Topics: Animals; Antihypertensive Agents; Aorta; Atenolol; Baroreflex; Blood Pressure; Captopril; Carotid Sinus; Denervation; Dose-Response Relationship, Drug; Male; Nifedipine; Pulse; Rats; Rats, Sprague-Dawley | 2006 |
Production and secretion of adiponectin from 3T3-L1 adipocytes: comparison of antihypertensive drugs.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Captopril; Hydrochlorothiazide; Losartan; Mice; Nifedipine; RNA, Messenger; Telmisartan | 2009 |
Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data.
Topics: Antihypertensive Agents; Atenolol; Captopril; Cardiovascular Diseases; Cost of Illness; Developing Countries; Health Services Accessibility; Humans; Hydrochlorothiazide; Losartan; Nifedipine; World Health Organization | 2010 |
Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension.
Topics: Adult; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Atenolol; Captopril; Case-Control Studies; Female; Humans; Hydrochlorothiazide; Hypertension; In Vitro Techniques; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Losartan; Male; Middle Aged; Neutrophils | 2011 |
Effects of antihypertensive drugs on specific harmonic indices of the pulse waveform in normotensive Wistar Kyoto rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Losartan; Male; Models, Animal; Models, Cardiovascular; Pulsatile Flow; Rats; Rats, Inbred WKY | 2012 |
Blockade of renin-angiotensin system prevents micturition dysfunction in renovascular hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Body Weight; Captopril; Cyclic AMP; Electric Stimulation; Female; Hypertension, Renovascular; Losartan; Male; Muscle Relaxation; Rats; Renin-Angiotensin System; Urethra; Urinary Bladder; Urination | 2014 |
Molecular interaction of some cardiovascular drugs with human serum albumin at physiological-like conditions: A new approach.
Topics: Amiodarone; Atenolol; Captopril; Cardiovascular Agents; Humans; Hydrophobic and Hydrophilic Interactions; Propranolol; Protein Binding; Serum Albumin, Human; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Static Electricity; Timolol | 2018 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enalapril; Government Programs; Humans; Hydrochlorothiazide; Hypertension; Losartan; Lymphocytes; Macrophages; Male; Mutagenicity Tests; Program Evaluation; Propranolol | 2018 |
Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aortic Aneurysm, Thoracic; Atenolol; Captopril; Humans; Magnetic Resonance Imaging | 2021 |